%20LIMITED%20-%2067819%2015-Dec-2008_files/image002.jpg){kind=small}
MIRA
INFORM REPORT
|
Report Date : |
15.12.2008 |
IDENTIFICATION
DETAILS
|
Name : |
SAMI PHARMACEUTICALS (PRIVATE) LIMITED |
|
|
|
|
Registered Office : |
34-C, Block-6, P.E.C.H.S., Karachi |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Year of Establishment : |
1971 |
|
|
|
|
Com. Reg. No.: |
0003496 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture and Marketing of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Business Name
SAMI PHARMACEUTICALS (PRIVATE) LIMITED
Full Address
|
Registered Address |
|
34-C, Block-6, P.E.C.H.S., Karachi, Pakistan. |
|
Tel |
92 (21) 4527490, 4527491, 4527492 |
|
Fax |
92 (21) 4549190, 4549190 |
|
|
Short Description Of Business
|
Nature of Business |
Manufacture & Marketing of Pharmaceutical Products |
|
Year Established |
1971 |
|
Registration # |
0003496 (Old
Registration # was 3227 /
19710907) |
Factory Location
|
Address |
F-95, Off. Hub River Road, S.I.T.E., Karachi-75730, Pakistan. |
|
Tel # |
92 (21) 2578081, 2578082, 2578083 |
|
Fax # |
92 (21) 2563934 |
Auditors
Mohammad Farooq & Co
(Chartered Accountants)
Legal Status
Subject Company was established as a Private Limited Company in 1971
|
Authorized Capital |
Rs. 2,000,000/- divided into 20,000 shares of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs. 1,671,100/- divided into 16,711 shares of Rs. 100/- each |
Details of Directors
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Shamim Ahmed Mr. Hafiz Ferozuddin Mr. Abdul Salam |
Pakistani Pakistani Pakistani |
X-37, Block-6, P.E.C.H.S., Karachi 29, Al Hamra Co-operative Housing Society, Shaheed-e-Millat Road, Karachi 373, Block-3, B.Y.J.C.H.S., Karachi |
Business Business Business |
Chief Executive Director Director |
Shareholders
|
Names |
No. of Shares |
|
Mr. Hafiz Ferozuddin Mrs Rehana Khatoon Mr. Amir Hafiz M. Umair Hafiz M. Saad Mrs. Farhana Mr. Shamim Ahmed Mr. Junaid Mr. Ovais Mr. Zubair Mr. Shoaib Mr. Abdul Salam Mrs. Humaira Mrs. Imrana Mrs. Ayesha Feroz |
257 1,050 3,376 387 520 1,523 83 1,528 3,389 1,407 1,200 269 719 503 500 |
Associates
A. Subsidiary
None
B. Associated Companies
- Do -
Products
AMMOIDIN, ANTIAL, BUEPRON, CARICEF, CHYMOTRIP, CONSPIC, DICLORAN, DICLOREP, DISGREN, EUPHEN, FLAVIN, KLINT, KLINZ, LOSPAN PLUS, MOVAX, MOXYPEN, NEUCEF, NOVIDAT, OXIDIL, PACE, PENCIT, PENORIT, PERIDONE, PROVAS, PULSATE, SAMEROL, SANTOVIR, SEDIL, TEPH 20, TRIMETABOL, UHASIL, ULCERAX, ZOLEN
Number of Employees
169
Actual Capacity & Production
The capacity and production of the Company’s plant is indeterminable as it is multi-product and involves varying processes of manufacture.
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2007 |
200,000,000/- (Estimated) |
Distributors
Mainly in all important cities of Pakistan
Bankers
(1) Askari Commercial Bank Limited, Shahrah-e-Faisal Branch, Karachi, Pakistan.
(2) Habib Metropolitan Bank Limited, Hirani Centre, I.I. Chundrigar Road, Karachi, Pakistan.
(3) Al-Baraka Islamic Bank, Lakhani Centre, I.I. Chundrigar
Road, Karachi, Pakistan.
Financial Position
Sound
Memberships
Pakistan Pharmaceutical Manufacturers Association.(PPMA)
Karachi Chamber of Commerce & Industry.(KCCI)
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 78.20 |
|
UK Pound |
1 |
Rs. 112.50 |
|
Euro |
1 |
Rs. 97.20 |
Comments
Subject is a
well-established company having fine track. Directors are reported as experienced,
respectable and having satisfactory means of their own. Trade relations are
reported as fair. Payments are usually correct and as per commitments. Company
can be considered for normal business dealings at usual trade terms and
conditions.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.47.82 |
|
UK Pound |
1 |
Rs.73.08 |
|
Euro |
1 |
Rs.65.56 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)